The following presentations were given at the Plenary Session of the Fall 2007 Group Meeting in Huntington Beach, California, "The Future of Clinical Trials in Southwest Oncology Group." They are in Windows Media Video format, and should automatically start in the default player for .wmv files on your computer when you click the icon at the right of the presentation title. The audio levels vary between and within presentations, because of technical problems during recording; please adjust your volume controls accordingly. Our apologies for this.

Saturday, October 6, 2007
Chair's Presentation Laurence H. Baker Chair, Southwest Oncology Group Professor, Internal Medicine & Pharmacology, University of Michigan Ann Arbor, Michigan
Developing Therapies to Target the Lethal Phenotype of Bone Metastases Kenneth Pienta, M.D. Professor of Internal Medicine and Urology, University of Michigan
What is the Future of Cancer Control and Prevention in the Southwest Oncology Group? Frank Meyskens, M.D. Director, Chao Family Comprehensive Cancer Center and Professor of Medicine and Biological Chemistry, University of California i Irvine
Translational Melanoma Research in the EORTC A. M. M. Eggermont, M.D., Ph.D. Professor of Medicine in Experimental Surgical Oncology, Department of Surgical Oncology, University Hospital Rotterdam Daniel Den Hoed Cancer Center, and President, European Organisation for Research and Treatment of Cancer
Perspectives in Placebo Control in Cancer Research Bruce Redman, D.O. Executive Officer, Southwest Oncology Group; Professor of Medicine, University of Michigan School of Medicine
	Discussant Gabriel Hortobagyi, M.D. Professor of Medicine and Chairman, Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center